Radiotherapy in Patients With Metastatic Esophageal Cancer Responding to PD-1 Inhibitor Plus Chemotherapy
Clinical trial NCT06084897 · RECRUITING
Trial details
- NCT number
- NCT06084897
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-16
- Primary completion
- 2026-04-26
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.